Zealand Pharma A/S
ZLDPF
$46.38
-$1.27-2.66%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1,089.21% | -2.38% | 6.68% | -105.50% | 2,537.70% |
| Total Depreciation and Amortization | -10.47% | 113.41% | -36.41% | 6.26% | 50.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 311.39% | 99.35% | -1,125.01% | -75.54% | 5,248.66% |
| Change in Net Operating Assets | -1,157.66% | -152.53% | 417.46% | -138.18% | 364.52% |
| Cash from Operations | 160.10% | 36.52% | -133.82% | -105.36% | 1,933.83% |
| Capital Expenditure | -29.32% | 41.51% | -359.95% | 46.39% | -25.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 321.47% | 70.72% | 58.34% | 44.06% | -401.40% |
| Cash from Investing | 291.23% | 69.40% | 56.56% | 44.07% | -406.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 11.11% | -50.45% | -10.45% | -8.32% | -25.00% |
| Issuance of Common Stock | 1,000.00% | -93.98% | 775.66% | -92.97% | 800.00% |
| Repurchase of Common Stock | -- | -- | -- | 77.48% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5,308.98% | -174.08% | 113.52% | 74.00% | -33,319.63% |
| Foreign Exchange rate Adjustments | -107.31% | 608.65% | -91.14% | 165.46% | -5,902.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.83% | 48.63% | -9.27% | -120.24% | 13,849.45% |